India’s Economic Crisis Took Their Jobs and Careers – and the ‘Recovery’ Hasn’t Brought Them Back
Contrary to the government’s claims of an economic recovery, millions of young Indians laid off last year remain jobless.
Two Key Numbers to Look Out for in the Upcoming Budget 2021
These are: how much did the government claim to have spent in 2020-21, and how much does it intend to spend in 2021-22. They will determine whether there is any real hope of sustained macroeconomic recovery in the near future.
Towards Universal Health Coverage? Taking Stock of Two Decades of Health Reforms in India
A survey of reforms in health policies in India over the past two decades – actually a string of privatisation policies – indicates that we have moved away from and not towards Universal Health Coverage. What then needs to be done?
Oxfam Report Shows Combined Pandemic Wealth of Richest 10 People Could Pay to Vaccinate Entire World
The world’s ten richest men, says an Oxfam report, have seen their combined wealth increase by half a trillion dollars since the pandemic began—more than enough to pay for a COVID-19 vaccine for everyone and to ensure no one is pushed into poverty by the pandemic.
Indian Billionaires Increased Their Wealth by 35% During the Lockdown, Says Oxfam Report
Mukesh Ambani earned ₹90 cr. an hour during the pandemic when around 24% of people in India were earning under ₹3,000 a month, says the report.
Investigate Neoliberal Leaders Who Failed to Protect Their Countries from COVID-19
The inaction of neoliberal and far-right governments to contain the pandemic and thus save tens of thousands of lives is criminal.
Under Cover of Covid-19, Modi Regime Steps Up its Attack on Indian Democracy
It has aimed its battering ram at the Indian Parliament, Indian federalism, the Indian press and Indian civil society organisations.
Vaccines Alone Aren’t Enough to Eradicate a Virus – Lessons from History
Smallpox eradication teaches that high-tech vaccinations only work when they are effectively combined with low-tech public health strategies.
India’s Vaccine Approvals – Many Unanswered Questions
There are many unknowns, and hence many questions, regarding the emergency-use approvals given by DGCI for two vaccine candidates in the country: Bharat Biotech’s Covaxin and Serum Institute’s Covishield.
Happy to be Part of Clinical Trials But Won’t Take Covaxin as a Vaccine: Gagandeep Kang
One of India’s top vaccine experts discusses her concerns regarding the manner in which Covaxin and Covishield have been approved for restricted emergency use.